Technical report

From Cancer Guidelines Wiki


This Technical Report accompanies the Clinical practice guidelines for Surveillance ColonoscopyAn examination of the large bowel using a camera on a flexible tube, which is passed through the anus., developed by Cancer Council Australia.

It outlines the guideline development process and methodology, lists the clinical questions, provides all accompanying NHMRCNational Health and Medical Research Council Statement Forms, the detailed technical documentation for each question and the risk of bias assessment tools used to assess the included literature as a result of a systematic review.

Guideline development process

Clinical question list

Evidence statement forms, systematic review reports and modelling reports

The following reports are for questions that were answered by a new systematic literature review or modelling. The associated technical documentation appears at the bottom of the relevant content pages.

The questions were given alphanumeric codes when they were developed, please refer to the codes below and see the Clinical question list for more detail.


SAD1: What should be the surveillance colonoscopy for patients are low risk (1-2 small <10mm tubular adenomas)?
Evidence statement form SAD1
Systematic review report SAD1
SAD2: What should be the surveillance colonoscopy for patients at high risk (size ≥10mm, HGDHigh grade dysplasia, villosity and/or 3-4 adenomas)?
Evidence statement form SAD2
Systematic review report SAD2
SAD3: What is the appropriate colonscopic surveillance after the removal of large sessile or laterally spreading adenomas?
Evidence statement form SAD3
Systematic review report SAD3
SAD4: What is the appropriate colonoscopic surveillance after the identification of sessile serrated adenomas and traditional serrated adenomas?
Evidence statement form SAD4
Systematic review report SAD4
SAD5: What should be the surveillance colonoscopy for patients with adenoma multiplicity?
Evidence statement form SAD5
Systematic review report SAD5
SFH1: Is the surveillance colonoscopy recommendation different for patients with adenomas who also have a family history of CRCColorectal cancer?
Evidence statement form SFH1
Systematic review report SFH1
COL1: What is the role of pre or peri-operative colonoscopy in CRCColorectal cancer patients?
Evidence statement form COL1
Systematic review report COL1
FUC1: At what time points after CRCColorectal cancer resection should surveillance colonoscopy be performed?
Systematic review report FUC1
SUR1: What is the appropriate time to commence surveillance in IBDInflammatory bowel disease patients (ulcerative colitis and Crohn’s patients, and effects of primary sclerosing cholangitis or family history of CRCColorectal cancer)?
Evidence statement form SUR1
Systematic review report SUR1
SUR2: What is the most appropriate time interval for surveillance in IBDInflammatory bowel disease patients based on risk?
Evidence statement form SUR2
Systematic review report SUR2
SUR3: What is the recommended surveillance strategies for surveillance in IBDInflammatory bowel disease patients?
Evidence statement form SUR3
Systematic review report SUR3
MNG1: What should be the protocol to manage elevated dysplasia in IBDInflammatory bowel disease?
Evidence statement form MNG1-4
Systematic review report MNG1
MNG2: What should be the protocol to manage high grade dysplasia in IBDInflammatory bowel disease?
Evidence statement form MNG1-4
Systematic review report MNG2
MNG3: What should be the protocol to manage low grade dysplasia in IBDInflammatory bowel disease?
Evidence statement form MNG1-4
Systematic review report MNG3
MNG4: What should be the protocol to manage indefinite dysplasia in IBDInflammatory bowel disease?
Evidence statement form MNG1-4
Systematic review report MNG4
Back to top